Inducible nitric oxide synthase (inos) and heart failure

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Over the last 15 years, the nitric oxide (NO) literature has experienced exponential growth (from 7 papers on endogenous NO in 1987 to over 45,000 in 2002). The link between inducible nitric oxide synthase (iNOS) and heart failure is accepted as an important association and is opening potential therapeutic avenues for the treatment of heart failure. Most literature suggests a deleterious effect of iNOS on heart function in dilated cardiomyopathy, ischemic cardiomyopathy, septic shock, cardiac allograft rejection, and viral and autoimmune myocarditis, although some controversial arguments continue.

Original languageEnglish (US)
Title of host publicationNutrition and Heart Disease
Subtitle of host publicationCausation and Prevention
PublisherCRC Press
Pages333-350
Number of pages18
ISBN (Electronic)9780203507629
ISBN (Print)9780849316746
StatePublished - Jan 1 2003

Fingerprint

Nitric Oxide Synthase Type II
Nitric Oxide
Heart Failure
Myocarditis
Dilated Cardiomyopathy
Septic Shock
Treatment Failure
Cardiomyopathies
Allografts
Growth
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yang, B., Larson, D. F., & Watson, R. R. (2003). Inducible nitric oxide synthase (inos) and heart failure. In Nutrition and Heart Disease: Causation and Prevention (pp. 333-350). CRC Press.

Inducible nitric oxide synthase (inos) and heart failure. / Yang, Bo; Larson, Douglas F; Watson, Ronald R.

Nutrition and Heart Disease: Causation and Prevention. CRC Press, 2003. p. 333-350.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yang, B, Larson, DF & Watson, RR 2003, Inducible nitric oxide synthase (inos) and heart failure. in Nutrition and Heart Disease: Causation and Prevention. CRC Press, pp. 333-350.
Yang B, Larson DF, Watson RR. Inducible nitric oxide synthase (inos) and heart failure. In Nutrition and Heart Disease: Causation and Prevention. CRC Press. 2003. p. 333-350
Yang, Bo ; Larson, Douglas F ; Watson, Ronald R. / Inducible nitric oxide synthase (inos) and heart failure. Nutrition and Heart Disease: Causation and Prevention. CRC Press, 2003. pp. 333-350
@inbook{feff686176544f959e3f9e4fac27f903,
title = "Inducible nitric oxide synthase (inos) and heart failure",
abstract = "Over the last 15 years, the nitric oxide (NO) literature has experienced exponential growth (from 7 papers on endogenous NO in 1987 to over 45,000 in 2002). The link between inducible nitric oxide synthase (iNOS) and heart failure is accepted as an important association and is opening potential therapeutic avenues for the treatment of heart failure. Most literature suggests a deleterious effect of iNOS on heart function in dilated cardiomyopathy, ischemic cardiomyopathy, septic shock, cardiac allograft rejection, and viral and autoimmune myocarditis, although some controversial arguments continue.",
author = "Bo Yang and Larson, {Douglas F} and Watson, {Ronald R}",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780849316746",
pages = "333--350",
booktitle = "Nutrition and Heart Disease",
publisher = "CRC Press",

}

TY - CHAP

T1 - Inducible nitric oxide synthase (inos) and heart failure

AU - Yang, Bo

AU - Larson, Douglas F

AU - Watson, Ronald R

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Over the last 15 years, the nitric oxide (NO) literature has experienced exponential growth (from 7 papers on endogenous NO in 1987 to over 45,000 in 2002). The link between inducible nitric oxide synthase (iNOS) and heart failure is accepted as an important association and is opening potential therapeutic avenues for the treatment of heart failure. Most literature suggests a deleterious effect of iNOS on heart function in dilated cardiomyopathy, ischemic cardiomyopathy, septic shock, cardiac allograft rejection, and viral and autoimmune myocarditis, although some controversial arguments continue.

AB - Over the last 15 years, the nitric oxide (NO) literature has experienced exponential growth (from 7 papers on endogenous NO in 1987 to over 45,000 in 2002). The link between inducible nitric oxide synthase (iNOS) and heart failure is accepted as an important association and is opening potential therapeutic avenues for the treatment of heart failure. Most literature suggests a deleterious effect of iNOS on heart function in dilated cardiomyopathy, ischemic cardiomyopathy, septic shock, cardiac allograft rejection, and viral and autoimmune myocarditis, although some controversial arguments continue.

UR - http://www.scopus.com/inward/record.url?scp=33646413542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646413542&partnerID=8YFLogxK

M3 - Chapter

SN - 9780849316746

SP - 333

EP - 350

BT - Nutrition and Heart Disease

PB - CRC Press

ER -